Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China · Delayed Price · Currency is CNY 10.31
+0.08 (0.78%)
Feb 3, 2026, 3:00 PM CST
SHA:600267 Revenue
Zhejiang Hisun Pharmaceutical had revenue of 2.67B CNY in the quarter ending September 30, 2025, with 1.57% growth. This brings the company's revenue in the last twelve months to 9.84B, up 3.02% year-over-year. In the year 2024, Zhejiang Hisun Pharmaceutical had annual revenue of 9.79B, down -5.65%.
Revenue (ttm)
9.84B
Revenue Growth
+3.02%
P/S Ratio
1.21
Revenue / Employee
1.23M
Employees
7,994
Market Cap
11.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.79B | -586.22M | -5.65% |
| Dec 31, 2023 | 10.37B | -1.66B | -13.82% |
| Dec 31, 2022 | 12.04B | -99.78M | -0.82% |
| Dec 31, 2021 | 12.14B | 782.07M | 6.89% |
| Dec 31, 2020 | 11.35B | 282.61M | 2.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition